A carregar...
Monoclonal Antibodies in Cancer Therapy: Mechanisms, Successes and Limitations
Rituximab was the first chemotherapeutic monoclonal antibody (CmAb) approved for clinical use in cancer therapeutics in 1997 and has significantly improved the clinical outcomes in non-Hodgkin's lymphoma. Since then, numerous CmAbs have been developed and approved for the treatment of various h...
Na minha lista:
| Publicado no: | West Indian Med J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
University of the West Indies
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4663950/ https://ncbi.nlm.nih.gov/pubmed/25803383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7727/wimj.2013.241 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|